Squarepoint’s Enzo Biochem, Inc. ENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $95.4K | Buy |
140,637
+13,197
| +10% | +$8.95K | ﹤0.01% | 2499 |
|
|
2025
Q1 | $47.2K | Buy |
127,440
+61,219
| +92% | +$22.7K | ﹤0.01% | 2618 |
|
|
2024
Q4 | $47.3K | Buy |
66,221
+9,575
| +17% | +$6.84K | ﹤0.01% | 2647 |
|
|
2024
Q3 | $63.4K | Buy |
+56,646
| New | +$63.4K | ﹤0.01% | 2410 |
|
|
2021
Q2 | – | Sell |
-102,282
| Closed | -$352K | – | 3116 |
|
|
2021
Q1 | $352K | Sell |
102,282
-67,148
| -40% | -$231K | ﹤0.01% | 1771 |
|
|
2020
Q4 | $427K | Buy |
169,430
+38,968
| +30% | +$98.2K | ﹤0.01% | 1603 |
|
|
2020
Q3 | $275K | Buy |
130,462
+117,373
| +897% | +$247K | ﹤0.01% | 1734 |
|
|
2020
Q2 | $29K | Buy |
+13,089
| New | +$29K | ﹤0.01% | 2067 |
|
|
2020
Q1 | – | Sell |
-73,442
| Closed | -$193K | – | 2557 |
|
|
2019
Q4 | $193K | Buy |
73,442
+11,055
| +18% | +$29.1K | ﹤0.01% | 2143 |
|
|
2019
Q3 | $225K | Sell |
62,387
-47,389
| -43% | -$171K | ﹤0.01% | 1938 |
|
|
2019
Q2 | $370K | Sell |
109,776
-110,176
| -50% | -$371K | ﹤0.01% | 1783 |
|
|
2019
Q1 | $600K | Buy |
219,952
+16,550
| +8% | +$45.1K | 0.01% | 1374 |
|
|
2018
Q4 | $565K | Buy |
203,402
+59,346
| +41% | +$165K | 0.01% | 1170 |
|
|
2018
Q3 | $594K | Buy |
144,056
+69,656
| +94% | +$287K | 0.01% | 1229 |
|
|
2018
Q2 | $386K | Buy |
74,400
+34,202
| +85% | +$177K | 0.01% | 1278 |
|
|
2018
Q1 | $220K | Buy |
40,198
+1,674
| +4% | +$9.16K | ﹤0.01% | 1452 |
|
|
2017
Q4 | $314K | Sell |
38,524
-7,476
| -16% | -$60.9K | 0.01% | 1461 |
|
|
2017
Q3 | $482K | Buy |
46,000
+34,600
| +304% | +$363K | 0.01% | 983 |
|
|
2017
Q2 | $126K | Buy |
+11,400
| New | +$126K | ﹤0.01% | 1373 |
|
|
2017
Q1 | – | Sell |
-11,238
| Closed | -$78K | – | 1955 |
|
|
2016
Q4 | $78K | Buy |
+11,238
| New | +$78K | ﹤0.01% | 1657 |
|